KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Abbott Laboratories (ABT) Long-Term Debt Issuances (2018 - 2025)

Abbott Laboratories (ABT) has disclosed Long-Term Debt Issuances for 9 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Issuances rose 100.0% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, down 97.76% year-over-year, with the annual reading at $5.0 million for FY2025, 97.76% down from the prior year.
  • Long-Term Debt Issuances hit $2.0 million in Q4 2025 for Abbott Laboratories, roughly flat from $2.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $221.0 million in Q2 2024 to a low of $1.0 million in Q3 2022.
  • Historically, Long-Term Debt Issuances has averaged $26.0 million across 5 years, with a median of $1.0 million in 2022.
  • Biggest five-year swings in Long-Term Debt Issuances: soared 300.0% in 2021 and later tumbled 99.1% in 2025.
  • Year by year, Long-Term Debt Issuances stood at $4.0 million in 2021, then plummeted by 75.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then surged by 100.0% to $2.0 million in 2025.
  • Business Quant data shows Long-Term Debt Issuances for ABT at $2.0 million in Q4 2025, $2.0 million in Q2 2025, and $1.0 million in Q1 2025.